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Introduction
Stress echocardiography and myocardial perfusion
imaging are commonly used noninvasive imaging
modalities for the evaluation of ischaemic heart
disease. Both modalities have proved clinically
useful in the entire spectrum of coronary artery
disease.1–29 Both techniques can detect cor-
onary artery disease and provide prognostic
information.1–21 Both techniques can identify low-
risk and high-risk subsets among patients with
known or suspected coronary artery disease and
thus guide patient management decisions.18–21 In
patients with acute myocardial infarction, both
techniques have been used to identify residual
viable tissue and predict improvement of function
over time.22–26 In patients with chronic ischaemic
left ventricular (LV) dysfunction, viability assess-
ment with either modality can be used to predict
improvement of function after revascularisation
and thus guide patient treatment.27–29
Hence, the use of noninvasive cardiac imaging
can help guide management and potentially reduce
healthcare costs.30 The question remains what is
the optimal noninvasive cardiac imaging method in
which setting? This article evaluates the value of
the two modalities in: (1) the detection of coronary
artery disease, (2) the prognosis of coronary artery
disease in patients with known or suspected cor-
onary artery disease, (3) prediction of functional
recovery following acute myocardial infarction and
(4) prediction of functional recovery after revascu-
larisation in patients with chronic ischaemic LV
dysfunction. To provide the most objective infor-
mation, only direct comparative studies on stress
echocardiography and perfusion imaging in the
same patients are included and pooled analysis of
the data was performed.
Methods
The available studies were identified by MEDLINE
searches using the following key words: noninvasive
imaging, stress echocardiography, dobutamine,
dipyridamole, adenosine, myocardial perfusion
imaging, technetium-99m sestamibi, technetium-
99m tetrofosmin and thallium-201. In addition, a
manual search of eight cardiology and nuclear
medicine journals (American Heart Journal,
American Journal of Cardiology, Circulation,
European Heart Journal, Heart, Journal of the
American College of Cardiology, Journal of Nuclear
Cardiology, Journal of Nuclear Medicine) from
January 1975 to 2001 was carried out. Only
studies that performed a head-to-head comparison
between stress echocardiography and some form of
nuclear imaging were selected. From these articles
the sensitivity and specificity of the techniques
were compared. Studies that did not provide this
information were excluded. From the pooled data,
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weighted sensitivities and specificities were calcu-
lated. Comparison of sensitivities and specificities
was performed using McNemar testing; a P-value
<0.05 was considered significant.
Results
Detection of coronary artery disease
Seventeen direct comparisons (1405 patients) with
different stressors (five exercise, two adenosine,
one dipyridamole, eight dobutamine, and one com-
bined adenosine and dobutamine) were identified
(Table 1). Pooling of the data showed a slightly
higher overall sensitivity for myocardial perfusion
imaging as compared to stress echocardiography
(84 vs 80%, P<0.05). This finding is in line with the
ischaemic cascade (Fig. 1), since perfusion abnor-
malities (detected by perfusion imaging) pro-
ceed systolic dysfunction (detected by stress
echocardiography).31
On the other hand, stress echocardiography was
more specific compared to perfusion imaging (86 vs
77%, P0.001). Fig. 2 demonstrates the differences
in sensitivity and specificity of the two modalities.
It should be noted that the gold standard for the
presence/absence of coronary artery disease was
angiography in these studies, which may affect
specificity of the tests. In the majority of the
studies ≥50% stenosis was used as the definition of
significant coronary artery disease. In the study of
Marwick et al.,9 results were also analysed with a
cutoff of >70% stenosis. The results were altered
little using this cutoff, as only four patients had a
stenosis severity of 50–70%.
Pharmacological stress can be a useful alterna-
tive to exercise stress protocols in patients who are
unable to exercise because of neurological, ortho-
pedic, or peripheral vascular disease. Because wall
motion abnormalities are a consequence of myocar-
dial ischaemia, dobutamine may be more effective
than vasodilator (adenosine or dipyridamole) stress
echocardiography.32 In line with this, combined
data from seven direct comparative studies demon-
strated that dobutamine stress echocardiography
had a higher sensitivity for the diagnosis of cor-
onary artery disease than vasodilator stress
echocardiography, while specificity was similar.
When dobutamine stress echocardiography was
compared to dobutamine or vasodilator perfusion
scintigraphy, dobutamine echocardiography was
equally sensitive but slightly more specific than
perfusion scintigraphy.33
Two subgroups of patients were analysed separ-
ately: hypertensive patients and female patients.
In patients with hypertension, abnormal thallium
perfusion results have been demonstrated in the
absence of obstructive coronary artery disease;34,35
this may lower specificity. Summarised data from
two studies (Table 2, 286 patients) have demon-
strated a somewhat higher sensitivity for perfusion
imaging compared to stress echocardiography (87
vs 74%, P<0.005), and confirmed the lower specifi-
city for perfusion imaging (44 vs 85%, P<0.001).36,37
The diagnosis of coronary artery disease in
women may be more challenging due to the lower
prevalence of coronary artery disease. In addition,
single-vessel disease is a common finding in
women.38,39 The accuracy of perfusion imaging
appears to be decreased in women with breast
tissue attenuation,39 and the smaller LV chamber
size in women.40 Pooled data from three direct
comparisons41–43 revealed a comparable sensi-
tivity of the two techniques (71 vs 80%, Pns) (175
patients, Table 2) with a higher specificity of stress
echocardiography for the detection of coronary
artery disease (72 vs 89%, P<0.01). Comparative
studies on adenosine stress imaging in patients with
hypertension and women are not available. Further
research on the relative value of adenosine stress
echocardiography and nuclear perfusion imaging in
these subgroups is needed.
Prognosis in coronary artery disease
Noninvasive cardiac imaging is frequently used for
risk stratification of patients with known or sus-
pected coronary artery disease. There are two
direct comparisons available on the prognostic
value of myocardial perfusion imaging and stress
echocardiography. Geleijnse et al.18 studied 220
patients with chest pain with dobutamine–atropine
stress echocardiography and simultaneous
technetium-99m sestamibi single photon emission
computed tomography (SPECT) imaging. During
follow-up of 31±15 months, 24 patients had hard
cardiac events (nonfatal myocardial infarction or
cardiac death). A normal test was related to a good
prognosis, with a low annual cardiac event rate of
0.4% by echocardiography and 0.5% by perfusion
imaging. In that study, stress echocardiography
and technetium-99m sestamibi SPECT provided
comparable prognostic information.
Olmos et al.19 studied 248 patients who under-
went exercise echocardiography simultaneously
with thallium-201 SPECT. During follow-up
(obtained in 225 patients with a mean follow-up of
3.7±2.0 years), 64 cardiac events occurred (eight
nonfatal infarctions and seven cardiac deaths).
A significant difference was observed between
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Table 1 Myocardial perfusion imaging vs stress echocardiography in the diagnosis of coronary artery disease
Author Year Pts Definition of
significant CAD
Stress Tracer Sensitivity Specificity
MPI Echocardiography MPI Echocardiography
Maurer1 1981 36 ≥50% stenosis Exercise Tl-201 74% (17/23) 83% (19/23) 92% (12/13) 92% (12/13)
Nguyen2 1990 25 ≥50% stenosis Adenosine Tl-201 90% (18/20) 60% (12/20) 100% (5/5) 100% (5/5)
Galanti3 1991 53 ≥70% stenosis Exercise Tl-201 100% (27/27) 53% (25/27) 92% (24/26) 96% (25/26)
Pozzoli4 1991 75 ≥50% stenosis Exercise Tc-99m 84% (41/49) 71% (35/49) 88% (23/26) 96% (25/26)
Quinones5 1992 112 ≥50% stenosis Exercise Tl-201 76% (65/86) 74% (64/86) 81% (21/26) 88% (23/26)
Salustri6 1992 44 ≥50% stenosis Exercise Tc-99m 77% (23/30) 67% (20/30) 86% (12/14) 71% (10/14)
Gunalp7 1993 27 ≥50% stenosis Dobutamine Tc-99m 94% (17/18) 83% (15/18) 88% (8/9) 88% (8/9)
Amanullah8 1993 40 ≥50% stenosis Adenosine Tc-99m 94% (32/34) 74% (25/34) 100% (6/6) 100% (6/6)
Marwick9 1993 97 ≥50% stenosis Adenosine Tc-99m 86% (51/59) 58% (34/59) 71% (27/38) 87% (33/38)
Marwick9 1993 97 ≥50% stenosis Dobutamine Tc-99m 80% (47/59) 85% (50/59) 74% (28/38) 82% (31/38)
Marwick10 1993 217 ≥50% stenosis Dobutamine Tc-99m 76% (108/142) 72% (102/142) 67% (50/75) 83% (62/75)
Forster11 1993 21 ≥50% stenosis Dobutamine Tc-99m 83% (10/12) 75% (9/12) 89% (8/9) 89% (8/9)
Senior12 1994 61 ≥50% stenosis Dobutamine Tc-99m 95% (42/44) 93% (41/44) 71% (12/17) 94% (16/17)
Ho13 1995 54 ≥50% stenosis Dobutamine Tl-201 98% (42/43) 93% (40/43) 73% (8/11) 73% (8/11)
Kisacik14 1996 69 ≥50% stenosis Dobutamine Tc-99m 96% (45/47) 94% (44/47) 64% (14/22) 86% (19/22)
Huang15 1997 93 ≥50% stenosis Dobutamine Tl-201 90% (60/67) 93% (62/67) 81% (21/26) 77% (20/26)
Parodi16 1999 101 ≥50% stenosis Dipyridamole Tc-99m 79% (63/80) 78% (62/80) 90% (19/21) 76% (16/21)
Smart17 2000 183 ≥50% stenosis Dobutamine Tc-99m 80% (95/119) 87% (104/119) 73% (47/64) 91% (58/64)
Pooled analysis 84% (803/959) 80% (765/959) 77% (345/446) 86% (385/446)










patients with normal and abnormal tests for all end
points, including death alone, for both modalities.
Overall cardiac event rate in patients with normal
test results was comparable for both exercise
echocardiography and thallium-201 SPECT (1.05 vs
1.13%, ns). Annual cardiac death rate was favorably
low for both normal echocardiography and normal
SPECT imaging (0.08 vs 0.08%, ns). Since only
two direct comparisons are available, more large
studies are required to fully elucidate the relative
prognostic value of myocardial perfusion imaging
and stress echocardiography.
Assessment of myocardial viability
The hallmark of viability on dobutamine echo-
cardiography is the improvement of wall motion
during the infusion of low-dose dobutamine
(5–10 µg kg−1 min−1). More recent studies have
employed a low-high dose protocol (with dosages
up to 40 µg kg−1 min−1, with the addition of atro-
pine). This protocol allows assessment of both
viability (response during low-dose dobutamine)
and stress-induced ischaemia (response during
high-dose dobutamine). For nuclear imaging, dif-
ferent techniques are available. Thallium-201
imaging can be used to evaluate perfusion and cell
membrane integrity. Two protocols are used
mainly: rest-redistribution imaging and stress-
redistribution-reinjection imaging.27–29 While rest-
redistribution imaging provides only information
on myocardial viability, the reinjection protocol
allows assessment of stress-induced ischaemia and
viability.
Technetium-99m sestamibi can be used to
assess perfusion and intact mitochondria. Sestamibi
imaging is performed under resting conditions; in
the absence of a stress study, this protocol only
provides information on viability. It has been
demonstrated that the addition of nitrates
before tracer administration enhances viability
detection.44
Glucose utilisation can be evaluated with
F18-fluorodeoxyglucose (FDG). FDG imaging can
nowadays be performed with positron emission
tomography and SPECT. The introduction of SPECT
imaging has contributed to a more widespread use
of FDG.45 Generally, cardiac FDG uptake is com-
pared with regional perfusion. Viability is defined
when perfusion/FDG uptake is normal, or when
perfusion is reduced with enhanced FDG uptake.
Prediction of functional recovery after acute
myocardial infarction
The phenomenon of reversible dysfunction after
myocardial infarction, known as stunning has been
well established.46,47 The presence of viable, but
stunned myocardium has been used to predict func-
tional recovery. Five studies22–26 with 209 patients
and 958 dyssynergic myocardial segments, com-
pared perfusion imaging with stress echocardiogra-
phy in the same patient population after acute
myocardial infarction and aimed at the prediction
of recovery of function (Table 3). All of these
studies used dobutamine stress, in most studies a
low-dose dobutamine protocol was employed for
echocardiography. Nuclear imaging tended to have
a higher sensitivity (although not significant),
Fig. 1 The ischaemic cascade represents a sequence of
pathophysiologic events caused by coronary artery disease.
Nuclear imaging probes an earlier event (hypo-perfusion) in the
ischaemic cascade than stress echocardiography does (systolic
dysfunction).
Fig. 2 Sensitivity and specificity of stress echocardiogra-
phy and nuclear imaging for the detection of coronary artery
disease (data based on Refs. 1–17). ,=echocardiography; j=
nuclear.
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whereas stress echocardiography was more
specific in the prediction of recovery of function
(Fig. 3).
Prediction of functional recovery after
revascularisation in chronic ischaemic LV
dysfunction
Table 4 shows the accuracy of different viability
techniques for the prediction of improvement of
function after revascularisation.29 The nuclear
imaging techniques appear to have a higher sensi-
tivity for the prediction of functional recovery
whereas stress echocardiography appears more
specific. Various studies have directly compared
some form of nuclear imaging to stress echo-
cardiography. Panza et al.48 have performed a
head-to-head comparison between thallium-201
imaging and dobutamine stress echocardiography in
patients with chronic ischaemic LV dysfunction. A
total of 311 segments were analysed by both tech-
niques; 84% of these were classified as viable and
16% as nonviable on thallium-201 imaging. The
majority of the ‘thallium-201 nonviable segments’
did not exhibit contractile reserve. However, an
additional 36% of the ‘thallium-201 viable seg-
ments’ also did not exhibit contractile reserve.
Thus, the results indicated that thallium-201 imag-
ing was more sensitive than dobutamine echo-
cardiography for the detection of viable tissue.
Similar results were obtained by Cornel et al.49 who
evaluated 40 patients with chronic ischaemic LV
dysfunction with FDG imaging and dobutamine
echocardiography. Again, nuclear imaging was
more sensitive for the detection of viable tissue as
Table 2 Myocardial perfusion imaging vs stress echocardiography in special patient subsets
Author Year Pts Definition
of significant
CAD






Elhendy36 1998 84 ≥50% stenosis Dobutamine Tc-99m 67% (44/66) 73% (48/66) 83% (15/18) 83% (15/18)
Fragasso37 1999 101 ≥50% stenosis Dipyridamole Tc-99m 98% (56/57) 61% (35/57) 36% (16/44) 91% (40/44)
Fragasso37 1999 101 ≥50% stenosis Dobutamine Tc-99m 98% (56/57) 88% (50/57) 36% (16/44) 80% (35/44)
Pooled
analysis
87% (156/180) 74% (133/180) 44% (47/106) 85% (90/106)
Women
Takeuchi41 1996 61 ≥50% stenosis Dobutamine Tl-201 78% (14/18) 72% (13/18) 70% (30/43) 91% (39/43)
Elhendy42 1998 70 ≥50% stenosis Dobutamine Tc-99m 64% (29/45) 78% (35/45) 72% (18/25) 92% (23/25)
Ho43 1998 44 ≥50% stenosis Dobutamine Tl-201 79% (19/24) 92% (22/24) 75% (15/20) 80% (16/20)
Pooled
analysis
71% (62/87) 80% (70/87) 72% (63/88) 89% (78/88)
MPI=myocardial perfusion imaging; Tc-99m=Technetium-99m; Tl-201=Thallium-201 chloride.
Table 3 Prediction of recovery of function after acute myocardial infarction: myocardial perfusion imaging vs stress
echocardiography
Author Year Pts Dyssynergic
segments
Techniques Sensitivity Specificity
MPI Echocardiography MPI Echocardiography
Elhendy22 1996 32 112 Tl-201 RR vs
LDDE
77% (27/35) 77% (27/35) 57% (44/77) 84% (65/77)
Le Feuvre23 1996 45 235 Tl-201 RI vs
LDDE
54% (59/109) 53% (58/109) 88% (111/126) 95% (120/126)
Smart24 1997 64 399 Tl-201 RR vs
HDDE
68% (140/207) 88% (183/207) 70% (134/192) 80% (153/192)
Spinelli25 1999 49 108 Tl-201 vs
LDDE
87% (53/61) 66% (40/61) 74% (35/47) 89% (42/47)
Anselmi26 2000 19 104 Tl-201 RR vs
LDDE
88% (23/26) 69% (18/26) 36% (28/78) 88% (69/78)
Pooled analysis 69% (302/438) 74% (326/438) 68% (352/520) 86% (449/520)
HDDE=low-high dose dobutamine echocardiography; LDDE=low-dose dobutamine echocardiography; MPI=myocardial perfusion
imaging; RI=reinjection; RR=rest-redistribution; Tl-201=thallium-201 chloride.
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evidenced by the 27% of the dysfunctional segments
with FDG uptake but without contractile reserve
(Fig. 4).
Various studies have subsequently compared
the predictive accuracy of nuclear imaging with
dobutamine echocardiography. Currently, a total of
18 studies50–67 (with 563 patients) have performed
a direct comparison between the two modalities
(Table 5). Different nuclear techniques were used:
three studies used FDG PET, five thallium-201 re-
injection and 10 thallium-201 rest-redistribution.
Two studies used low-high dose dobutamine
echocardiography and the remaining 16 used low-
dose dobutamine echocardiography. Pooling of
these data yielded a higher sensitivity for nuclear
imaging (88 vs 76%, P<0.05) and a higher specificity
for dobutamine echocardiography (81 vs 53%,
P<0.05). In eight studies (see Table 5), some form
of stress imaging (either thallium-201 reinjection or
low-high dose dobutamine echocardiography) was
used; to make the comparison more balanced (and
only restricted to viability assessment) the analysis
was repeated after exclusion of these eight studies.
The discrepancy between nuclear imaging and
dobutamine echocardiography for the prediction of
functional outcome after revascularisation became
even more outspoken (Fig. 5).
It is conceivable that different levels of ultra-
structural cell damage account for this discrep-
ancy: the inotropic response during dobutamine
stimulation may be lost while more basal character-
istics such as cell membrane integrity and glucose
utilisation are still intact. Besides prediction of
improvement of function after revascularisation,
prediction of long-term survival may be more
important. Currently, no direct comparative
studies are available on the prognostic value of
nuclear imaging and stress echocardiography in
patients with ischaemic cardiomyopathy.
Recent developments: simultaneous
assessment of function and perfusion
Recently, different technical developments have
been implemented in both perfusion imaging and
stress echocardiography that further optimised the
techniques. Myocardial perfusion imaging has been
improved by the introduction of new cameras,
imaging protocols, attenuation and scatter correc-
tion.68,69 For echocardiography, second harmonic
imaging has markedly improved endocardial border
detection, which could even be further enhanced
by intravenous administration of contrast agents
that opacify the LV cavity.70–72 Colour kinesis
and tissue Doppler echocardiography may allow
quantification of function,73,74 which may enhance
reproducibility and diagnostic accuracy.
Other recent developments have aimed at
providing integrated information on function and
perfusion. Both gated SPECT imaging and contrast
echocardiography allow simultaneous assessment
of function and perfusion.75,76 Over the past 5 years
ECG-gated SPECT has become state-of-the-art
in cardiac myocardial perfusion imaging. Various
comparative studies have demonstrated excellent
accuracy of gated SPECT for the assessment of both
regional and global LV function.77 Smanio et al.78
have demonstrated that combination of perfusion
and function (assessed by gating) resulted in signifi-
cantly higher diagnostic accuracy for detection/
exclusion of coronary artery disease. Moreover, the
integrated information of function and perfusion
allows superior prognostification in patients with
known or suspected coronary artery disease, as
demonstrated recently by Sharir et al.79
Contrast echocardiography also allows simulta-
neous assessment of function and perfusion. With
the introduction of contrast agents that can be
administered intravenously, the use of contrast
echocardiography has now become feasible outside
the catheterisation laboratory. In combination with
harmonic and intermittent imaging, quantitative
assessment of perfusion has become possible.
Recently, Kaul et al.80 have shown an excellent
concordance between contrast echocardiography
and myocardial perfusion imaging. In 30 patients,
the agreement for detecting absence/presence of
coronary artery disease was 86%. However, two
multicentre trials have demonstrated a less favour-
able agreement between perfusion imaging and
Fig. 3 Sensitivity and specificity of dobutamine stress echocar-
diography and nuclear imaging for the prediction of functional
outcome in acute myocardial infarction (data based on Refs.
22–26).,=DSE; j=nuclear.
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contrast echocardiography.81,82 Marwick et al.81
showed that, for the detection of extensive per-
fusion defects on SPECT perfusion imaging, contrast
echocardiography had a sensitivity ranging from 13
to 48% with a specificity ranging from 63 to 100%.
Jucquois et al.82 suggested that the discrepancy
between the two techniques could in part be
related to attenuation artifacts on SPECT (inferior
wall) and suboptimal visualisation of the anterior
and lateral walls by echocardiography. However, in
experienced settings, adequate quantification of
myocardial blood flow and quantification of cor-
onary artery stenoses is possible, as demonstrated
by Wei and colleagues.83,84 Besides detection of
coronary artery disease, evaluation of patients with
acute myocardial infarction is feasible with con-
trast echocardiography and is particularly useful for
assessment of ‘the no-reflow phenomenon’ after
thrombolysis or percutaneous interventions.85,86
Finally, the feasibility of contrast echocardiogra-
phy for assessment of viability after acute infarc-
tion87 and in the setting of chronic LV dysfunction88
has been demonstrated.
Thus, in the near future, the combined assess-
ment of perfusion and function by echocardiography
and SPECT will allow a more complete assessment of
patients with coronary artery disease.
Clinical implications and conclusions
Both myocardial perfusion imaging and stress
echocardiography have proved to be extremely
useful noninvasive tests for the evaluation of cor-
onary artery disease.1–29 Due to basic differences
between the two tests, perfusion imaging is a
sensitive test with a somewhat lower specificity
Table 4 Accuracy of the different viability techniques (data based on pooled analysis of data available in the literature29)
Technique No. of studies No. of pts Sensitivity (%) Specificity (%) PPV (%) NPV (%)
DSE 32 1090 81 80 77 85
Tl-201 RR 22 557 86 59 69 80
Tl-201 RI 11 301 88 50 57 83
MIBI 20 488 81 66 71 77
FDG PET 20 598 93 58 71 86
DSE=dobutamine stress echocardiography; FDG=F18-fluorodeoxyglucose; MIBI=technetium-99m sestamibi; NPV=negative
predictive value; PET=positron emission tomography; PPV=positive predictive value; RR=rest-redistribution; RI=reinjection;
Tl-201=thallium-201 chloride.
Fig. 4 Agreement and disagreement between FDG SPECT and low-dose dobutamine echocardiography in dysfunctional myocardium
(reprinted with permission from Cornel et al.49).
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for the detection of coronary artery disease; the
converse is true for stress echocardiography.1–17
This systematic review focuses on direct compara-
tive studies on stress echocardiography and per-
fusion imaging in order to provide the most
objective information. Nevertheless, a potential
risk of pooling data from different studies is to
mix patients with different clinical characteristics
and risk profile.
Two available direct head-to-head comparative
studies demonstrated a similar prognostic value of
perfusion imaging and stress echocardiography.
Larger comparisons are needed to draw further
conclusions.
For the assessment of myocardial viability after
acute infarction the modalities seem to be equally
sensitive, whereas stress echocardiography is the
more specific test.22–26 Hence, for the early assess-
ment of viability stress echocardiography may be
preferable. However, specificity is determined by
segments that are nonviable that do not improve in
function. A lower specificity suggests that a sub-
stantial percentage of segments that are viable
do not recover in function. Most studies have
evaluated recovery of function at a rather short
time-interval after infarction (<3 months) and
longer follow-up may be needed.
In patients with chronic ischaemic ven-
tricular dysfunction, nuclear imaging has a high
sensitivity for the detection of viable myo-
cardium and a low specificity, whereas the con-
verse is true for stress echocardiography.50–67
The lower specificity of nuclear imaging can
again be an issue of duration of follow-up. Re-
cent data have demonstrated that a substantial
percentage of segments need longer time after
revascularisation to (fully) recover in function.89
In addition, large direct comparative studies
are required to evaluate the prognostic value of
nuclear imaging and stress echocardiography in
patients with chronic ischaemic left ventricular
dysfunction.
Table 5 Head-to-head comparisons between nuclear imaging and dobutamine echocardiography for the prediction of improve-
ment of regional function post-revascularisation (table modified from Ref. 29)
Author Techniques Assessing No. of pts
Gerber50 FDG PET vs LDDE V vs V 39
Baer51 FDG PET vs LDDE V vs V 42
Pagano52 FDG PET vs LDDE V vs V 30
Vanoverschelde53 Tl-201 RI vs LDDE V+I vs V 73
Arnese54 Tl-201 RI vs LDDE V+I vs V 38
Bax55 Tl-201 RI vs LDDE V+I vs V 17
Haque56 Tl-201 RI vs LDDE V+I vs V 26
Kostopoulos57 Tl-201 RI vs LDDE V+I vs V 31
Marzullo58 Tl-201 RR vs LDDE V vs V 14
Qureshi59 Tl-201 RR vs HDDE V vs V+I 34
Alfieri60 Tl-201 RR vs LDDE V vs V 13
Perrrone-Filardi61 Tl-201 RR vs LDDE VvsV 18
Charney62 Tl-201 RR vs LDDE V vs V 14
Nagueh63 Tl-201 RR vs HDDE V vs V+I 19
Pace64 Tl-201 RR vs LDDE V vs V 46
Senior65 Tl-201 RR vs LDDE V vs V 22
Sicari66 Tl-201 RR vs LDDE V vs V 57
Gunning67 Tl-201 RR vs LDDE V vs V 30
FDG=F 18-fluorodeoxyglucose; HDDE=low-high dose dobutamine echocardiography; I=stress-inducible ischaemia; LDDE=
low-dose dobutamine echocardiography; PET=positron emission tomography; RI=reinjection; RR=rest-redistribution; Tl-201=
thallium-201 chloride; V=viability.
Fig. 5 Bar graph illustrating sensitivities and specificities of
nuclear imaging and dobutamine stress echocardiography to
predict improvement of function post-revascularisation in
patients with chronic ischaemic left ventricular dysfunction
(data based on Refs. 50–52,58,60–62).,=DSE; j=nuclear.
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In conclusion, the current analysis demonstrated
that both techniques are useful in the evaluation of
patients with coronary artery disease, although
small differences between accuracies exist in dif-
ferent settings. The most important factor for using
a test remains the local expertise and availability of
these imaging modalities. In addition, patient char-
acteristics (habitus, acoustic window, pregnancy)
may influence the choice of the technique, and
finally the studies discussed generally reflect the
experience in university centers and many of these
studies may be influenced by selection and referral
bias, which limits application of the results to the
general population.
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